STOCK MARKET BSE NSE

Granules inks pact to buy Auctus Pharma

Pharma firm Granules India Ltd on Monday signed a definitive agreement to acquire 100 per cent stake in privately-held Auctus Pharma for an undisclosed sum.

Published: 14th November 2013 08:45 AM  |   Last Updated: 14th November 2013 08:45 AM   |  A+A-

Pharma firm Granules India Ltd on Monday signed a definitive agreement to acquire 100 per cent stake in privately-held Auctus Pharma for an undisclosed sum.

The acquisition of Auctus, an Active Pharma Ingredients (API) producer, is expected to be completed in the next 3 to 6 months.

Auctus operates an API facility in Pharmacity, Visakhapatnam and an intermediate facility in Hyderabad and has all necessary approvals in place from regulatory agencies such as the US Food and Drug Administration, European Directorate for the Quality of Medicines & Healthcare (EDQM), Health Canada, Korea Food and Drug Administration and WHO-Good Manufacturing Practices, Granules said in a statement.

“Auctus provides Granules with an API platform having the US FDA approved site to strengthen its finished dosage division...,” said Krishna Prasad, Managing Director, Granules India, whose profit after tax during the first half of the current financial year stood at `31 crore.

Meanwhile, Granules has announced the setting up of a 10,000 sq ft Research & Development facility in Hyderabad that will focus on full scale generic API development besides supplementing the company’s existing R&D facility in Pune.

“The acquisition is one part of our three-prong growth strategy. In addition, our team is eagerly awaiting the commercializatoin of our third growth driver, Granules OmniChem, a collaboration with Ajinomoto OmniChem, a premier CRAMs manufacturer,” said Harsha Chigurupati, Executive Director, Granules India.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp